Frequently Asked Questions About UNBX

What does Unity Biotechnology, Inc. do?

Unity Biotechnology, Inc. (UNBX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is UNBX's market cap?

Unity Biotechnology, Inc. (UNBX) has a market capitalization of approximately $965,603, as of October 14, 2025, based on the most recent share price and shares outstanding.

Does UNBX pay a dividend?

No — Unity Biotechnology, Inc. (UNBX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is UNBX profitable?

Unity Biotechnology, Inc. (UNBX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

UNBX (Unity Biotechnology, Inc.) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

UNBX

Unity Biotechnology, Inc.

OTC·Biotechnology · Healthcare

$0.06$0.00+0.00%

Market cap$965.60K·Market closed·Oct 14 8:00 PM UTC

Price Chart

$0.06+$0.00 (+0.00%)today

−99.82%CAGR −71.92%

Select date range

FromTo

May 3, 2018Aug 27, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

UNBX does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateJul 22

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how UNBX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for UNBX and 80,000+ other tickers.

About Unity Biotechnology, Inc.

Unity Biotechnology, Inc. functions as a biotechnology enterprise dedicated to creating innovative treatments aimed at slowing down, stopping, or even reversing illnesses associated with the aging process. A core component of their therapeutic development involves senolytic compounds, specifically designed to address various ocular (eye) and neurological conditions.

CEO: Craig R. Jalbert
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 16
Website: unitybiotechnology.com/pipeline/

Peers

Peers Tab

BIOR

Biora Therapeutics, Inc.

Evofem Biosciences, Inc.

Cap

$1.0M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About UNBX

What does Unity Biotechnology, Inc. do?: Unity Biotechnology, Inc. (UNBX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is UNBX's market cap?: Unity Biotechnology, Inc. (UNBX) has a market capitalization of approximately $965,603, as of October 14, 2025, based on the most recent share price and shares outstanding.
Does UNBX pay a dividend?: No — Unity Biotechnology, Inc. (UNBX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is UNBX profitable?: Unity Biotechnology, Inc. (UNBX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.